Macfarlane K. Angela 4
4 · RenovoRx, Inc. · Filed Oct 2, 2024
Insider Transaction Report
Form 4
RenovoRx, Inc.RNXT
Macfarlane K. Angela
Director
Transactions
- Award
Stock Options (right to buy)
2024-10-01+25,099→ 25,099 totalExercise: $1.02Exp: 2034-10-01→ Common Stock (25,099 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2024.